ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Epimedium koreanum

Also known as: Epimedium koreanum, Horny Goat Weed, Yin Yang Huo

Overview

Epimedium koreanum, commonly known as Horny Goat Weed, is a plant native to Korea and parts of Asia. It has a long history of use in traditional medicine, particularly in Traditional Chinese Medicine (TCM), where it is valued for its purported aphrodisiac and health-promoting properties. The plant contains various flavonoids, with icariin being the most well-known and believed to be responsible for many of its effects. Epimedium is often used to address conditions such as erectile dysfunction, infertility, and osteoporosis. It is available in various forms, including capsules, tablets, powders, and extracts. While research is ongoing, the existing evidence suggests potential benefits, particularly in improving bone mineral density and reducing pain associated with osteoporosis. However, more high-quality studies are needed to fully understand its efficacy and safety.

Benefits

Epimedium koreanum has shown potential benefits in several areas, primarily related to bone health and sexual function. Studies suggest that it can improve bone mineral density (BMD) and reduce pain in osteoporosis patients. A meta-analysis indicated significant improvements in BMD when Epimedium was used alone or in combination with conventional treatments. Traditionally, it has been used as an aphrodisiac, though clinical evidence supporting this is limited. Some research suggests potential anti-inflammatory and antioxidant properties, but these effects are not as well-studied in humans. Postmenopausal women may particularly benefit from Epimedium for osteoporosis treatment, as indicated by studies on Epimedium total flavonoids. The effect sizes for BMD improvement are statistically significant, but the clinical significance may vary depending on the individual and the specific study.

How it works

Epimedium koreanum's mechanism of action is primarily attributed to its flavonoid content, especially icariin. Icariin is believed to mimic estrogenic effects in the body, which can contribute to its osteoprotective properties by influencing bone metabolism. It interacts with the endocrine system through these estrogenic activities. Additionally, Epimedium may exert anti-inflammatory effects, potentially contributing to its therapeutic benefits. Estrogen receptors are likely molecular targets for icariin, influencing bone health. The absorption and bioavailability of icariin and other flavonoids in Epimedium are not well-documented and may vary based on the preparation and individual factors.

Side effects

Epimedium koreanum is generally considered safe when used appropriately, but more data are needed on long-term safety and potential interactions. Common side effects are not well-documented, but gastrointestinal issues may occur. Uncommon side effects include the potential for allergic reactions or interactions with other medications. Specific rare side effects are not well-documented. Due to its flavonoid content, Epimedium may interact with blood thinners and other medications. It is contraindicated in pregnancy and breastfeeding due to a lack of safety data. Caution is advised in patients with hormone-sensitive conditions or those taking medications that interact with estrogen. It is important to consult with a healthcare provider before using Epimedium, especially if you have underlying health conditions or are taking other medications.

Dosage

While a minimum effective dose is not well-established, typical doses range from 500 mg to 1,000 mg per day of Epimedium extract. Optimal dosing for specific conditions like osteoporosis may require further research. A maximum safe dose is not clearly defined, but high doses should be approached with caution. Consistent daily dosing is recommended for chronic conditions like osteoporosis. Extracts standardized for icariin content may be preferred for therapeutic use. Bioavailability may be influenced by the presence of other nutrients or herbal components. No specific cofactors are known to be required for Epimedium's efficacy. It is crucial to adhere to recommended dosages and consult with a healthcare professional to determine the appropriate dose for individual needs.

FAQs

How should I take Epimedium koreanum?

Consistent daily use is recommended, especially for chronic conditions. Follow the dosage instructions on the product label or as advised by your healthcare provider. It can be taken with or without food.

How long does it take to see results?

Improvements in bone mineral density (BMD) may take several months to become apparent. Individual results may vary, and it is not a cure-all for sexual dysfunction or osteoporosis.

Are there any risks associated with taking Epimedium?

Potential risks include gastrointestinal issues, allergic reactions, and interactions with blood thinners or hormone-sensitive medications. Consult with a healthcare provider before use, especially if you have underlying health conditions.

Can Epimedium koreanum cure erectile dysfunction?

Epimedium has traditionally been used for enhancing sexual function, but clinical evidence is limited. It is not a guaranteed cure for erectile dysfunction, and individual results may vary. Consult with a healthcare provider for appropriate treatment options.

Research Sources

  • https://pubmed.ncbi.nlm.nih.gov/37544344/ – This study is a systematic review and meta-analysis involving 1,017 patients across 12 RCTs. It found significant improvements in bone mineral density (BMD) and pain reduction in osteoporosis patients with Epimedium treatment. The study highlights the potential of Epimedium in managing osteoporosis, noting benefits with durations over three months.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC9008843/ – This systematic review and meta-analysis focuses on the efficacy and safety of Epimedium total flavonoids for primary osteoporosis. It provides a comprehensive overview of the current evidence base for Epimedium in osteoporosis treatment. The study is limited by the availability of high-quality studies, but it offers valuable insights into the potential benefits of Epimedium for bone health.
  • https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1415265/full – This review discusses the traditional uses and phytochemical composition of Epimedium koreanum. It provides valuable information on the plant's historical applications and chemical constituents. While it does not provide clinical trial data, it is useful for understanding the traditional uses and chemical composition of Epimedium.
  • https://www.publish.csiro.au/hc/pdf/HC24183 – This is a PDF document. Without further context, it's difficult to provide a specific summary. Please provide more information about the content of this document to generate an accurate summary.
  • https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1505926/full – This study evaluates the efficacy and safety of Epimedium total flavonoids for primary osteoporosis. It provides a comprehensive overview of the current evidence base for Epimedium in osteoporosis treatment. The study is limited by the availability of high-quality studies, but it offers valuable insights into the potential benefits of Epimedium for bone health.